SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-141857
Filing Date
2024-05-17
Accepted
2024-05-17 17:07:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d817743d424b3.htm 424B3 22627
2 GRAPHIC g817743g0517113802331.jpg GRAPHIC 6608
  Complete submission text file 0001193125-24-141857.txt   33023
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 24961205
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)